MRM Health and Biocodex establish strategic partnership to strengthen future commercial supply capabilities for CORAL®-based medicines

November 6, 2026 - 13:26

MRM Health, a biotech company focused on developing microbiome-based treatments for immune-mediated diseases, has partnered with Biocodex, a well-established French pharmaceutical firm with over 70 years of expertise in the microbiome sector. This collaboration aims to create specialized manufacturing capabilities for live biotherapeutic products, marking a significant step forward in the production of CORAL-based medicines.

The partnership is expected to leverage the strengths of both companies, combining MRM Health's innovative approach to microbiome therapies with Biocodex's extensive experience in the pharmaceutical industry. By enhancing their commercial supply capabilities, the two companies are positioning themselves to better meet the growing demand for microbiome-based treatments.

This strategic alliance underscores the importance of collaboration in the biotech field, particularly as the understanding of the microbiome's role in health continues to evolve. With this partnership, MRM Health and Biocodex are set to make meaningful advancements in the development and availability of effective therapies for patients.